Company Filing History:
2 out of 2 
2 out of 1,290 
Years Active: 2022
Title: Yusuke Yamazumi: Innovator in Gene Expression Inhibition
Introduction
Yusuke Yamazumi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of gene expression inhibition, particularly concerning the MEX3B gene. With a total of 2 patents, his work focuses on developing therapeutic agents that target specific gene expressions.
Latest Patents
Yamazumi's latest patents include innovative methods and nucleic acids that inhibit the expression of the MEX3B gene. His inventions provide a nucleic acid that can inhibit MEX3B gene expression with low cytotoxicity as a side effect. Additionally, he has developed a method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5. These advancements are crucial for creating effective treatments for various diseases linked to these interleukins.
Career Highlights
Throughout his career, Yusuke Yamazumi has worked with notable organizations, including Tak-Circulator Co., Ltd and The University of Tokyo. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in gene expression.
Collaborations
Yamazumi has collaborated with esteemed colleagues such as Tetsu Akiyama and Kazuyoshi Kofu. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yusuke Yamazumi's innovative work in gene expression inhibition showcases his dedication to advancing medical science. His patents and collaborations highlight the importance of targeted therapies in treating diseases related to gene expression.